Holocene Advisors’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$15.4M Hold
2023
Q1
$12M Sell
2022
Q4
$26.2M Sell
2022
Q3
$32.4M Hold
2022
Q2
$28.8M Hold
2022
Q1
$35.5M Buy
2021
Q4
$29.9M Buy
2021
Q3
$35.2M Buy
2021
Q2
$24.6M Buy
2021
Q1
$13.3M Buy